Question

A 35-year-old woman with newly diagnosed hypertension (average 150/96 mmHg) and no comorbidities is assessed using the 2023 Australian CVD risk calculator; her 5-year CVD risk is 12%. What is the most appropriate management regarding pharmacotherapy?

Accepted Answer

Start BP-lowering therapy and lipid-modifying therapy

Answer

Lifestyle modification only; no pharmacotherapy at this risk level

Answer

Start aspirin for primary prevention only

Answer

Start lipid-modifying therapy but defer BP-lowering therapy

Answer

Start beta blocker monotherapy regardless of other factors

Practice question

A 35-year-old woman with newly diagnosed hypertension (average 150/96 mmHg) and no comorbidities is assessed using the 2023 Australian CVD risk calculator; her 5-year CVD risk is 12%. What is the most appropriate management regarding pharmacotherapy?